Latest Breaking News On - அட்லஸ் பயோமெட் குழு - Page 1 : comparemela.com

Share this article Share this article ResearchAndMarkets.com s offering. The global human microbiome market is projected to reach USD 1,598 million by 2028 from USD 894 million in 2025, at a CAGR of 21.3% from 2025 to 2028. The major factor driving the growth of the human microbiome market is the increasing focus on human microbiome therapy development. The human microbiome as a validated target for drug development & development of human microbiome-based tests for early disease detection and diagnosis are also factors expected to support market growth. However, a lack of expertise and inadequate research on the human microbiome are factors expected to restrain this market s growth.

United statesUnited kingdomLaura woodAtlas biomed groupEvelo biosciences incOptibiotix health united kingdomVithera pharmaceuticalsVithera pharmaceuticals incFinch therapeutics group incResearch technology genomicsDaytwo incOptibiotix healthQuantbiome incOffice hours callInadequate researchFerring pharmaceuticals switzerland